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Carotenoids are pigments naturally occurring in plants, particularly in dark-green leafy vegetables
such as raw spinach and cooked kale, and they have many functions in human tissues. Lutein is
the dominant carotenoid found in adult and in infant brain especially in the neocortex and in the
neural retina, however diet intake is needed because it cannot be synthesized in the body (Costa
et al., 2013). Preterm infants have been deprived from carotenoid transfer during the last weeks of
pregnancy and after birth the only sources are breast milk or oral supplementation. Concerning
carotenoids, it has long been assumed that their intestinal absorption occurs by passive diffusion.
Recently the high inter-individual variability in absorption observed in human studies argues
in favor of the existence of putative membrane transporters of carotenoids. After uptake by the
enterocyte, a substantial quantity of carotenoids up to 40% of the dietary intake is not metabolized.
It is assumed that the major fraction of carotenoids are incorporated into chylomicrons that
are secreted into the lymph (Reboul, 2013). Carotenoid composition of human milk changes
during the first month postpartum. Lutein represents only 20% of carotenoids in colostrum but
nearly 50% in mature milk. During the first month postpartum all four carotenoids (lutein,
β-cryptoxanthin, lycopene, and α-carotene) decrease in the milk but lutein remains relatively
elevated probably because it plays an important role for the infant (Gossage et al., 2002). Lutein
concentration in breast milk correlates with mother plasma concentration and lutein intake during
the third trimester of pregnancy. There is a dose-dependent response to lutein supplementation in
lactating women. Previous studies (Sherry et al., 2014) demonstrated that lutein supplementation
in pregnant women increases breast milk lutein concentration and provides plasma increase in
their infants. Mothers who received higher doses of lutein supplementation had higher value
of lutein concentration in plasma than mothers who received lower doses or placebo. However
arterial cord blood lutein levels in addition to maternal plasma concentrations seem to be sex,
gestational age and delivery mode dependent. Lutein levels are lower in males and in newborns
delivered by cesarean section (Picone et al., 2012). However, post-mortem infant brain samples
analyzed for lutein by HPLC did not show any difference in the levels of lutein between males
and females (Lieblein-Boff et al., 2015). Arterial cord blood level of lutein is higher in preterm
infants, especially at the early stage of the third trimester, than in term infants. It is possible to
speculate that increased value of carotenoids in this period is related to the role in promoting central
nervous system development. Lutein and zeaxanthin are found in the eye and are concentrated in
the foveal depression of the macula. Previous studies (Vishwanathan et al., 2013) demonstrated
a correlation between carotenoid macula concentration and brain value. The measure of total
macular pigment may be a tool in investigating the role of lutein in cognitive functions. Retinal
lutein is significantly related to lutein level in the occipital cortex. Renzi et al. (2013) found
a relationship between macular pigments and visuo-motor response in humans. Carotenoids
can enhance gap junctional communication in cell and can ameliorate visual function because
gap junctions are crucial to light processing within the retina. Macular pigment optical density
correlates with diet intake and with age (Bernstein et al., 2013). Lutein may improve neuroretinal
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FIGURE 1 | Lutein.
maturation in preterm infants and it is predominant in brain
development; these findings confirm that lutein is important
for neurodevelopment in the infant but the mechanism
is not completely clear (Lieblein-Boff et al., 2015). Post-
mortem metabolomic analyses were performed on human
infant brain tissues (hippocampus, frontal cortex, occipital
cortex) commonly involved in learning and memory to
study the interaction between nutrients, lutein, and products
of cellular metabolism (e.g., nucleotides, sugars and amino
acids; Lieblein-Boff et al., 2015). Fatty acids and amino acid
neurotransmitters are positively correlated with lutein in infant
brain. Lutein seems to promote maturation of cell membranes
and cortical folding and seems to support the oligodendrocyte
maturation. Furthermore lutein increases neurotransmitters
GABA concentration (Lieblein-Boff et al., 2015). GABA seems
to play an important role in modulating neuronal proliferation,
maturation and synapse formation (Lieblein-Boff et al., 2015).
These findings could explain the effects of carotenoids on
cognitive functions and temporal processing speed in young
(Lieblein-Boff et al., 2015). Anti-inflammatory, antioxidant and
light-absorbing characteristics of carotenoids could be important
for neonates especially for preterm babies to prevent the
pathogenesis of common diseases of prematurity that may be
related to poor neurodevelopmental outcome (e.g., necrotizing
enterocolitis, retinopathy of prematurity, bronchopulmonary
dysplasia; Rubin et al., 2012). Inflammation generates reactive
oxygen species (ROS) that can attack DNA, RNA, lipids
and proteins activating various signaling pathways that could
cause diseases. In intrauterine life there is very low oxygen
concentration but after birth higher levels of oxygen are
available for the newborn and ROS as singlet oxygen and
hydroxyl radicals are produced (Perrone et al., 2014). Lutein
with a hydroxyl group attached to either ends of the
molecule can react with singlet oxygen and can neutralize
ROS (Figure 1). Oxidative stress (OS), can increase during
pregnancy, and it can lead to cellular and tissue damage.
Lorenzoni et al. (2013) investigated the oxidative status of
diabetic pregnant women and of their babies. Oxidative stress
is lower in pregnant women receiving lutein and in their
newborns than in untreated mothers and newborns showing
that lutein administration during pregnancy significantly reduces
neonatal OS at birth. Furthermore infants fed with lutein-
supplemented formula seem to develop less severe retinopathy
of prematurity (ROP) than control group and they have
lower value of plasma C-reactive protein (CRP) (Rubin
et al., 2012). These findings may be due to carotenoid
immunomodulatory properties (Rubin et al., 2012). Manzoni
et al. (2013) in a multicenter, double-blind, randomized
controlled trial with lutein supplementation in preterm babies
confirmed that threshold ROP incidence tended to be lower
in the lutein treated vs. not treated infants. They also found
that less severe forms of bronchopulmonary dysplasia (BPD)
and necrotizing enterocolitis (NEC) were associated to lutein
supplementation. Lutein is a bioactive compound and its
potential epigenetic effect on neurodevelopment in preterm
infants deserves further studies (Ferguson and Schlothauer,
2012). More studies are necessary to better understand the
effects of lutein administration to mothers and newborns and
the toxicity of these compounds. If beneficial effects of lutein
are confirmed at the tested dosages, this compound should
be considered as a potential therapy for the prevention of
bronchopulmonary dysplasia, necrotizing enterocolitis and other
diseases of prematurity.
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